SCHEMBL3789140

SCHEMBL3789140

COc1ccc(N)c(-c2ccc(N)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.56
MAPK1 P28482 1/20 0.56
ALDH1A1 P00352 8/20 0.54
CYP3A4 P08684 6/20 0.54
APP P05067 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
MAPT P10636 4/20 0.47
HPGD P15428 3/20 0.47
NPC1 O15118 2/20 0.47
TP53 P04637 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
RAB9A P51151 2/20 0.47
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444778 0.89 TDP1 (0.57) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL453782 0.89 TDP1 (0.56) TDP1MAPK1ALDH1A1CYP3A4APP
Hydrochloric Acid SCHEMBL6574161 0.87 ALDH1A1 (0.57) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL1578362 0.85 MEN1 (0.50) MAPK1ALDH1A1CYP3A4CYP1A2CYP2D6
SCHEMBL21708253 0.85 RELA (0.55) ALDH1A1CYP3A4APPCYP1A2CYP2D6
SCHEMBL28113571 0.85 HDAC3 (0.49) TDP1MAPK1ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL29492486 0.85 ALDH1A1 (0.50) MAPK1ALDH1A1CYP3A4SMN1; SMN2CYP1A2
SCHEMBL3785577 0.85 ALDH1A1 (0.50) MAPK1ALDH1A1CYP3A4SMN1; SMN2CYP1A2
SCHEMBL3794745 0.85 TDP1 (0.56) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL11004268 0.83 ALDH1A1 (0.61) TDP1MAPK1ALDH1A1CYP3A4APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 TDP1 4196/4885MAPK1 4726/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.